Free Trial

West Pharmaceutical Services (WST) Competitors

West Pharmaceutical Services logo
$314.49 -23.63 (-6.99%)
(As of 11/15/2024 ET)

WST vs. COO, ALGN, MMSI, HAE, ICUI, XRAY, NEOG, QDEL, STAA, and CERS

Should you be buying West Pharmaceutical Services stock or one of its competitors? The main competitors of West Pharmaceutical Services include Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), Neogen (NEOG), QuidelOrtho (QDEL), STAAR Surgical (STAA), and Cerus (CERS). These companies are all part of the "health care supplies" industry.

West Pharmaceutical Services vs.

West Pharmaceutical Services (NYSE:WST) and Cooper Companies (NASDAQ:COO) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, valuation, media sentiment, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.

West Pharmaceutical Services has a net margin of 17.37% compared to Cooper Companies' net margin of 9.45%. West Pharmaceutical Services' return on equity of 18.41% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
West Pharmaceutical Services17.37% 18.41% 13.74%
Cooper Companies 9.45%9.08%5.88%

West Pharmaceutical Services has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500.Comparatively, Cooper Companies has a beta of 0.99, suggesting that its stock price is 1% less volatile than the S&P 500.

In the previous week, Cooper Companies had 10 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 19 mentions for Cooper Companies and 9 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 1.12 beat Cooper Companies' score of 0.51 indicating that West Pharmaceutical Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
West Pharmaceutical Services
6 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cooper Companies
6 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Positive

West Pharmaceutical Services has higher earnings, but lower revenue than Cooper Companies. West Pharmaceutical Services is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
West Pharmaceutical Services$2.95B7.72$593.40M$6.7446.66
Cooper Companies$3.59B5.52$294.20M$1.8055.50

Cooper Companies received 355 more outperform votes than West Pharmaceutical Services when rated by MarketBeat users. Likewise, 66.63% of users gave Cooper Companies an outperform vote while only 55.74% of users gave West Pharmaceutical Services an outperform vote.

CompanyUnderperformOutperform
West Pharmaceutical ServicesOutperform Votes
262
55.74%
Underperform Votes
208
44.26%
Cooper CompaniesOutperform Votes
617
66.63%
Underperform Votes
309
33.37%

93.9% of West Pharmaceutical Services shares are held by institutional investors. Comparatively, 24.4% of Cooper Companies shares are held by institutional investors. 0.5% of West Pharmaceutical Services shares are held by insiders. Comparatively, 2.0% of Cooper Companies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

West Pharmaceutical Services presently has a consensus price target of $460.33, suggesting a potential upside of 46.37%. Cooper Companies has a consensus price target of $117.00, suggesting a potential upside of 17.43%. Given West Pharmaceutical Services' higher probable upside, analysts clearly believe West Pharmaceutical Services is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
West Pharmaceutical Services
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Cooper Companies
0 Sell rating(s)
3 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.75

Summary

West Pharmaceutical Services beats Cooper Companies on 10 of the 18 factors compared between the two stocks.

Get West Pharmaceutical Services News Delivered to You Automatically

Sign up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WST vs. The Competition

MetricWest Pharmaceutical ServicesSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$22.78B$4.56B$5.07B$19.81B
Dividend Yield0.25%39.56%5.10%3.50%
P/E Ratio46.6625.28101.9242.29
Price / Sales7.7255.021,196.9520.78
Price / Cash33.2251.7441.0421.65
Price / Book8.285.486.344.66
Net Income$593.40M$13.76M$119.64M$983.45M
7 Day Performance-2.97%-6.52%-5.13%-2.12%
1 Month Performance8.97%2.19%-2.72%-0.39%
1 Year Performance-8.25%50.62%31.10%23.34%

West Pharmaceutical Services Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WST
West Pharmaceutical Services
4.9796 of 5 stars
$314.49
-7.0%
$460.33
+46.4%
-8.6%$22.78B$2.95B46.6610,600Analyst Revision
Positive News
COO
Cooper Companies
3.5067 of 5 stars
$102.00
-1.5%
N/A+17.0%$20.31B$3.59B56.8215,000Analyst Upgrade
Short Interest ↑
News Coverage
ALGN
Align Technology
4.692 of 5 stars
$219.09
-2.7%
N/A+10.1%$16.36B$3.86B37.3921,610
MMSI
Merit Medical Systems
4.3915 of 5 stars
$104.24
+0.1%
N/A+42.2%$6.08B$1.26B51.106,950Short Interest ↑
Positive News
HAE
Haemonetics
4.784 of 5 stars
$93.38
+2.2%
N/A+0.0%$4.78B$1.36B38.753,657Analyst Forecast
News Coverage
High Trading Volume
ICUI
ICU Medical
4.1571 of 5 stars
$178.01
-0.1%
N/A+92.7%$4.35B$2.30B-60.9614,000Analyst Downgrade
Short Interest ↓
News Coverage
XRAY
DENTSPLY SIRONA
4.9012 of 5 stars
$17.77
+0.7%
N/A-38.2%$3.60B$3.90B-8.5815,000
NEOG
Neogen
2.224 of 5 stars
$15.34
-6.5%
N/A-8.5%$3.32B$924.22M-139.452,640
QDEL
QuidelOrtho
4.437 of 5 stars
$41.14
-4.3%
N/A-44.8%$2.77B$2.83B-1.477,100Options Volume
STAA
STAAR Surgical
4.8603 of 5 stars
$29.02
-4.6%
N/A-24.4%$1.43B$341.22M65.951,115Short Interest ↓
CERS
Cerus
2.8499 of 5 stars
$1.89
-6.9%
N/A-0.6%$350.99M$156.37M-17.18625Short Interest ↑
Gap Down

Related Companies and Tools


This page (NYSE:WST) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners